Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Nov 29;36(6):e00416.
doi: 10.1042/BSR20160385. Print 2016 Dec.

Liver glucose metabolism in humans

Affiliations
Review

Liver glucose metabolism in humans

María M Adeva-Andany et al. Biosci Rep. .

Abstract

Information about normal hepatic glucose metabolism may help to understand pathogenic mechanisms underlying obesity and diabetes mellitus. In addition, liver glucose metabolism is involved in glycosylation reactions and connected with fatty acid metabolism. The liver receives dietary carbohydrates directly from the intestine via the portal vein. Glucokinase phosphorylates glucose to glucose 6-phosphate inside the hepatocyte, ensuring that an adequate flow of glucose enters the cell to be metabolized. Glucose 6-phosphate may proceed to several metabolic pathways. During the post-prandial period, most glucose 6-phosphate is used to synthesize glycogen via the formation of glucose 1-phosphate and UDP-glucose. Minor amounts of UDP-glucose are used to form UDP-glucuronate and UDP-galactose, which are donors of monosaccharide units used in glycosylation. A second pathway of glucose 6-phosphate metabolism is the formation of fructose 6-phosphate, which may either start the hexosamine pathway to produce UDP-N-acetylglucosamine or follow the glycolytic pathway to generate pyruvate and then acetyl-CoA. Acetyl-CoA may enter the tricarboxylic acid (TCA) cycle to be oxidized or may be exported to the cytosol to synthesize fatty acids, when excess glucose is present within the hepatocyte. Finally, glucose 6-phosphate may produce NADPH and ribose 5-phosphate through the pentose phosphate pathway. Glucose metabolism supplies intermediates for glycosylation, a post-translational modification of proteins and lipids that modulates their activity. Congenital deficiency of phosphoglucomutase (PGM)-1 and PGM-3 is associated with impaired glycosylation. In addition to metabolize carbohydrates, the liver produces glucose to be used by other tissues, from glycogen breakdown or from de novo synthesis using primarily lactate and alanine (gluconeogenesis).

Keywords: diabetes; glucokinase; glucose; hexosamine pathway; pentose phosphate pathway.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Summary of glucose utilization in the human liver
Figure 2
Figure 2. Phosphoglucomutase-1 and Phosphoglucomutase-3 reactions
Figure 3
Figure 3. Glucose 1-phosphate uridyltransferase or uridine 5′diphosphate (UDP)-glucose pyrophosphorylase (UGP) reactions
Figure 4
Figure 4. Galactose metabolism
Figure 5
Figure 5. Hexosamine pathway
Figure 6
Figure 6. UDP-N-acetylglucosamine pyrophosphorylase reactions
Figure 7
Figure 7. Pentose phosphate pathway
Figure 8
Figure 8. Integrative figure of liver glucose metabolism

Similar articles

Cited by

References

    1. Ferrannini E., Bjorkman O., Reichard G.A., Jr, Pilo A., Olsson M., Wahren J., DeFronzo R.A. The disposal of an oral glucose load in healthy subjects. A quantitative study. Diabetes. 1985;34:580–588. - PubMed
    1. Fukumoto H., Seino S., Imura H., Seino Y., Eddy R.L., Fukushima Y., Byers M.G., Shows T.B., Bell G.I. Sequence, tissue distribution, and chromosomal localization of mRNA encoding a human glucose transporter-like protein. Proc. Natl. Acad. Sci. U.S.A. 1988;85:5434–5438. doi: 10.1073/pnas.85.15.5434. - DOI - PMC - PubMed
    1. Takeda J., Kayano T., Fukomoto H., Bell G.I. Organization of the human GLUT2 (pancreatic beta-cell and hepatocyte) glucose transporter gene. Diabetes. 1993;42:773–777. doi: 10.2337/diab.42.5.773. - DOI - PubMed
    1. Adkins A., Basu R., Persson M., Dicke B., Shah P., Vella A., Schwenk W.F., Rizza R. Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in nondiabetic humans. Diabetes. 2003;52:2213–2220. doi: 10.2337/diabetes.52.9.2213. - DOI - PubMed
    1. Ban N., Yamada Y., Someya Y., Miyawaki K., Ihara Y., Hosokawa M., Toyokuni S., Tsuda K., Seino Y. Hepatocyte nuclear factor-1alpha recruits the transcriptional co-activator p300 on the GLUT2 gene promoter. Diabetes. 2002;51:1409–1418. doi: 10.2337/diabetes.51.5.1409. - DOI - PubMed